Caliber Imaging & Diagnostics Names Daniel Koon to Director of Global Sales Support
13 Marzo 2014 - 5:30AM
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid,
Inc., has named Daniel Koon to Director of Global Sales Support,
effective immediately. Mr. Koon most recently served as Caliber
I.D.'s Research Sales Manager, and prior to that held other
positions within the company.
Mr. Koon has experience in international sales and support of
Caliber's VivaScope® devices for research applications in clinical
and preclinical dermatology. He has spent extended periods in
Europe to help develop and implement strategies to assist the
Company's European distribution partner MAVIG GmbH. He first joined
Caliber more than 12 years ago, starting out as an engineering
technician involved in the design and manufacturing aspects of the
business, with subsequent promotions to Sales Application Engineer,
Executive Account Manager and then Research Sales Manager.
Mr. Koon holds a bachelor's degree in mathematics and physics
from the State University of New York College at Potsdam.
Mr. Koon said, "As I have been actively involved in global
sales, sales support and engineering for the VivaScope system, I
believe I have a unique understanding of it, and the procedures
that need to be adhered to as the Company seeks to grow its medical
and therapeutic research business. In my new role at Caliber, I
look forward to helping to increase our support capability for our
distribution partners around the globe."
L. Michael Hone, Chief Executive Officer of Caliber I.D., said,
"Having begun his career at Caliber as an engineer, Dan is
extremely well-versed in VivaScope's technology, and he has the
added advantage of having been an instrumental part of establishing
business with our European distributor. In his new role, he will
continue to build our customer support infrastructure. These
activities are critical in helping us to generate additional
revenue as we concurrently focus on the clinical side of the
business. We expect him to excel in these efforts, mirroring his
earlier success in facilitating our distribution in Europe."
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' proprietary, cutting-edge
VivaScope(R) system is a disruptive, noninvasive point-of-care
platform imaging technology with numerous applications in
dermatology, surgery and research. FDA 510(k) cleared, VivaScope
has regulatory approval in most major markets. With 78 issued or
pending patents worldwide, VivaScope significantly improves
outcomes and reduces costs, allowing physicians to quickly detect
cancerous lesions that appear benign. VivaScope dramatically
reduces the need for expensive, painful and time-consuming
biopsies, which show no malignancy approximately 70% of the time.
VivaScope also has significant applications in testing and analysis
in the cosmetics industry. For more information about Caliber I.D.
and its products, please visit www.caliberid.com.
VivaScope(R) is a registered trademark of Caliber Imaging &
Diagnostics.
Safe Harbor
This press release contains "forward looking statements" within
the meaning of the Securities Litigation Reform Act of 1995. These
statements are based on our current beliefs or expectations and are
inherently subject to significant known and unknown uncertainties
and changes in circumstances, many of which are beyond our control.
There can be no assurance that our beliefs or expectations will be
achieved and actual results may differ materially from our beliefs
or expectations due to financial, economic, business, regulatory
and other factors or conditions affecting us or our industry in
general, as well as more specific risks and uncertainties facing
us, such as those set forth in the Risk Factors section of the
Forms 10-Q and 10-K filed by us with the Securities and Exchange
Commission.
CONTACT: Company Contact:
Richard Pulsifer
Chief Financial Officer
(617) 348-9821
Public Relations Contacts:
Dian Griesel Int'l.
Susan Forman or Laura Radocaj
(212) 825-3210
sforman@dgicomm.com
lradocaj@dgicomm.com
Caliber Imaging and Diag... (CE) (USOTC:LCDX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Caliber Imaging and Diag... (CE) (USOTC:LCDX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024